Data: 08/08/2026
Total encontrado: 7
1/7US=11 / UTI
Conishi RMY, Monachini M, Mitushima SM. Cuidados com cateteres. In: Schettino G, Cardoso LF, Mattar Júnior J, Torggler Filho F. Paciente crítico: diagnóstico e tratamento: Hospital Sírio Libanês. São Paulo: Manole, 2006. p. 883-93.

CATETERES. CUIDADOS; CATETER PERIFERICO; CATETER VENOSO; ARTERIA PULMONAR; BALAO INTRA-AORTICO; BLOQUEIOS. SORO FISIOLOGICO; HEPARINA; UROKINASE; MONITORIZACOES PRESSAO

2/7US=85 / Biol/Mol
Hong No J, Jo H, Kim SH, Park IA, Kang D, Lee CH, Han SS, Kim JW, Park NH, Kang SB, Song YS. Expression of MMP-2, MMP-9, and urokinase-type plasminogen activator in cervical intraepithelial neoplasia. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 100-4. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

NEOPLASIA INTRA-EPITELIAL CERVICAL; MATRIZ METALOPROTEINASE; UROQUINASE TIPO-PLASMINOGENIO

3/7US=65 / Biol/Mol
D'Alessio S, Blasi F. The urokinase plasminogen activator receptor as a target for cancer therapy. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 223-43. ISBN 978-0-387-69056-8.

RECEPTOR UROQUINASE; ATIVADOR DO PLASMINOGENIO; TERAPIA DO CANCER; SISTEMA UPA/UPAR; TRANSDUCAO DE SINAL; MOTILIDADE CELULAR; PROLIFERACAO CELULAR; CANCER; ESTRATEGIAS TERAPEUTICAS ANTISENSE; APOPTOSE

4/7US=65 / Biol/Mol
Degryse B. The urokinase receptor and integrins constitute a cell migration signalosome. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 451-74. ISBN 978-0-387-69056-8.

RECEPTOR DE UROCINASE; INTEGRINAS; MIGRACAO CELULAR

5/7US=65 / Biol/Mol
Jacobsen B, Kjaergaard M, Gardsvoll H, Ploug M. Structure and inhibition of the urokinase-type plasminogen activator receptor. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 699-719. ISBN 978-0-387-69056-8.

ATIVADOR DO PLASMINOGENIO TIPO UROQUINASE; UPAR; ANTICORPOS MONOCLONAIS; ANTAGONISTAS PEPTIDICOS

6/7US=2 / Mama
Duffy MJ. Tissue predictive biomakers: urokinase-type plasminogen activator and PAI-1. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 111-28. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4.

BIOMARCADORES PREDITIVOS; UROQUINASE; PLASMINOGENIO; PAI-1; CANCER; MARCADORES TUMORAIS; CANCER DE MAMA

7/7US=246 / Tese/FAP
Anelli A. Determinação da relação entre a expressão do sistema de ativação do plasminogênio e o prognóstico em câncer de mama feminino localmente avançado. [Relationship between the expression of plasminogen activation system and prognosis in locally advanced female breast cancer]. São Paulo, 2009. 46 p. Tese(Doutorado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/Doutorado/2009/us246.pdf

Curriculum Lattes

CANCER DE MAMA; QUIMIOTERAPIA; ATIVADORES DE PLASMINOGENIO; PROGNOSTICO; TISSUE ARRAY